Latest News about COVID/19 Vaccine
Recent news which mentions COVID/19 Vaccine
Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests
February 25, 2022
From Benzinga
Canada Approves First Plant-Based COVID-19 Vaccine
February 25, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Valneva Secures £20M From Scottish Enterprise For Vaccine Development
February 22, 2022
Tickers
VALN
From Benzinga
FDA Lifts Clinical Hold On Ocugen's COVID-19 Vaccine Study In US
February 22, 2022
Tickers
OCGN
From Benzinga
From Benzinga
Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters
February 17, 2022
Tickers
MRNA
From Benzinga
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
February 16, 2022
From Benzinga
Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs
February 16, 2022
Tickers
MRNA
From Benzinga
Pfizer, Moderna COVID-19 Boosters Effectiveness Wanes After Four Months: CDC Study
February 14, 2022
From Benzinga
FDA Postpones Adcomm For Pfizer's COVID-19 Vaccine For Youngest Kids
February 14, 2022
From Benzinga
From Benzinga
Novavax's COVID-19 Vaccine Shows 80% Effectiveness In Adolescent Study
February 11, 2022
Tickers
NVAX
From Benzinga
US Plans COVID-19 Vaccine Roll Out For Kids Under 5 Years This Month
February 10, 2022
From Benzinga
Johnson & Johnson Halts Production Of Its COVID-19 Vaccine: NYT
February 08, 2022
Tickers
JNJ
From Benzinga
Germany's Vaccine Commission Recommends Novavax's COVID-19 Vaccine For Adults: Reuters
February 04, 2022
From Benzinga
FDA Asks Pfizer - BioNTech To Submit For COVID-19 Vaccine Emergency Use Nod For Youngest Children
February 02, 2022
From Benzinga
Canadian Politician To Musk's Pro-Convoy Stance: 'STFU Elon'
February 01, 2022
Tickers
TSLA
From Benzinga
From Benzinga
From Benzinga
iBio Advances Its Vaccine Program for Multi-Variant COVID-19 Disease
January 26, 2022
Tickers
IBIO
From Benzinga
From Benzinga
Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial
January 25, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.